BrightInsight to Showcase Key Updates to its BrightInsight Platform and Disease Management Solution at HLTH 2023
SAN JOSE, Calif. and LAS VEGAS, Oct. 04, 2023 (GLOBE NEWSWIRE) -- BrightInsight, Inc., provider of the leading global platform for biopharma and medtech digital health solutions, announced today that it will showcase the latest technical enhancements to the BrightInsight® Platform and Disease Management Solution at the HLTH conference taking place October 8–11, 2023, in Las Vegas.
- SAN JOSE, Calif. and LAS VEGAS, Oct. 04, 2023 (GLOBE NEWSWIRE) -- BrightInsight, Inc., provider of the leading global platform for biopharma and medtech digital health solutions, announced today that it will showcase the latest technical enhancements to the BrightInsight® Platform and Disease Management Solution at the HLTH conference taking place October 8–11, 2023, in Las Vegas.
- Since initially launching the BrightInsight Platform in 2018, the company has invested over $100M in its underlying infrastructure – which allows it to deliver industry-leading scalability, functionality, configurability, speed, compliance and global availability.
- “BrightInsight allows life sciences companies to deploy differentiating customer-facing solutions faster, with configurable, out-of-the-box features.
- The Platform can now support NFC and Bluetooth connectivity for medical device integrations across multiple device types, such as blood pressure, blood glucose, heart rate, weight and temperature monitors.